Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Scribe Therapeutics, Inc.Listing unverified | Buy | $144.3K | conv 33Cluster | SEC | |
Scribe Therapeutics, Inc.Listing unverified | Buy | $1.1M | conv 39ClusterFirst in 12mo | SEC | |
Scribe Therapeutics, Inc.Listing unverified | Buy | $35M | conv 70ClusterFirst in 12mo | SEC | |
Scribe Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Whitehawk Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Whitehawk Therapeutics, Inc.Listing unverified | AwardD (derivative) | $20M | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | SellD (derivative) | $1.5K | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | SellD (derivative) | $245 | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | BuyD (derivative) | $10M | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | SellD (derivative) | $1K | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | SellD (derivative) | $300 | SEC | ||
Whitehawk Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CAL-BAY INTERNATIONAL INCListing on record | BuyD (derivative) | $15M | First in 12mo | SEC | |
CAL-BAY INTERNATIONAL INCListing on record | BuyD (derivative) | $10M | First in 12mo | SEC | |
Whitehawk Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Whitehawk Therapeutics, Inc.Listing unverified | Award | $25M | SEC | ||
IMMUNOMEDICS INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
IMMUNOMEDICS INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
IMMUNOMEDICS INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
IMMUNOMEDICS INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
IMMUNOMEDICS INCListing unverified | Buy | $49.9M | conv 47Unusual size | SEC | |
IMMUNOMEDICS INCListing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
IMMUNOMEDICS INCListing unverified | Buy | $35M | conv 67ClusterUnusual size+1 | SEC | |
Mirati Therapeutics, Inc.Listing unverified | Sell | $6.4M | SEC | ||
IMMUNOMEDICS INCListing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |